Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs KMX✓SelectedUSD · KMXGSK vs KMX performance historyLatest closeAs of-0.13%11/20
Stock and ETF performance explorer

GSK vs KMX

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+52.7%
KMX return
-24.6%
Excess return
+77.3%
Maximum drawdown
-28.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioKMXExcessAlpha
1D-0.1%-3.9%+3.8%+0.1%
7D-5.3%-9.7%+4.3%-4.7%
30D-3.7%-6.6%+3.0%-3.3%
3M-7.3%-21.3%+14.0%-6.1%
6M-4.2%+28.8%-33.0%-5.4%
YTD+0.9%+24.4%-23.5%-0.4%
1Y+7.3%+43.4%-36.1%+5.3%
3Y+52.7%-26.1%+78.8%+51.7%
All+52.7%-24.6%+77.3%+51.7%

Cumulative growth

Daily Returns

Daily percentage return beside KMX.

Daily Out/Under-Performance

Portfolio return minus KMX return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × KMX return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded KMX wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling